Table 1. Demographic and clinical characteristics of the study patients.
| Variable | Patients with cysts (n=66)a |
|---|---|
| Age (y), median (range) | 67.5 (38-89) |
| Sex | |
| Male | 38 |
| Female | 28 |
| Primary tumors | |
| Colon cancer | 57 |
| Breast cancer | 3 |
| Lung cancer | 5 |
| Ovarian cancer | 1 |
| Average does of bevacizumab (mg/kg/wk) | 2.63 |
| 5 mg/kg every 2 weeks (n) | 42 |
| 7.5 mg/kg every 2 weeks (n) | 20 |
| 10 mg/kg every 3 weeks (n) | 1 |
| 15 mg/kg every 3 weeks (n) | 3 |
| Median duration of bevacizumab therapy (wk) | 31 (8-104 ) |
a:Two patients were lost to follow-up, leaving 64 patients for evaluation.